The goal of this observational study is to characterize the epidemiology and natural history of MPS diseases by building a retrospective and prospective collection of extensive phenotypic data from French MPS patients.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Evaluation of the clinical data of MPS like growth for each system
Timeframe: Through study completion, an average of 5 years
Evaluation of the clinical data of MPS like signs for each system
Timeframe: Through study completion, an average of 5 years
Evaluation of the clinical data of MPS like symptoms for each system
Timeframe: Through study completion, an average of 5 years
Evaluation of the clinical data of MPS like complications for each system
Timeframe: Through study completion, an average of 5 years
Evaluation of the clinical data of MPS like psychomotor milestones
Timeframe: Through study completion, an average of 5 years
Evaluation of the clinical data of MPS like cognitive evolution
Timeframe: Through study completion, an average of 5 years
Evaluation of the clinical data of MPS like handicap using scales adapted to multivisceral disease for all types of MPS
Timeframe: Through study completion, an average of 5 years
Evaluation of the clinical data of MPS like handicap using scales adapted to cognitive and neurologic disease for the types I, II, III VII
Timeframe: Through study completion, an average of 5 years
Evaluation of the radiological data of MPS like standard bone radiographs
Timeframe: Through study completion, an average of 5 years
Evaluation of the radiological data of MPS like abdominal echography
Timeframe: Through study completion, an average of 5 years
Evaluation of the radiological data of MPS like echocardiography
Timeframe: Through study completion, an average of 5 years
Evaluation of the radiological data of MPS like cerebral and medullar tomodensitometry
Timeframe: Through study completion, an average of 5 years
Evaluation of the radiological data of MPS like magnetic resonance imaging
Timeframe: Through study completion, an average of 5 years
Evaluation of the electrophysiological data of MPS like EMG
Timeframe: Through study completion, an average of 5 years
Evaluation of the electrophysiological data of MPS like EEG
Timeframe: Through study completion, an average of 5 years
Evaluation of the electrophysiological data of MPS like ERG
Timeframe: Through study completion, an average of 5 years
Evaluation of the biochemical data of MPS like urinary GAG before specific treatment
Timeframe: Through study completion, an average of 5 years
Evaluation of the biochemical data of MPS like urinary GAG during specific treatment
Timeframe: Through study completion, an average of 5 years
Evaluation of the biochemical data of MPS like enzyme activities before specific treatment
Timeframe: Through study completion, an average of 5 years
Evaluation of the biochemical data of MPS like enzyme activities during specific treatment
Timeframe: Through study completion, an average of 5 years
Evaluation of the biochemical data of MPS like specific antibodies
Timeframe: Through study completion, an average of 5 years
Evaluation of the molecular data of MPS
Timeframe: Through study completion, an average of 5 years